乳腺X线、简化与全序列MRI诊断早期乳腺癌的比较
本研究基于病理结果,比较FFDM、DBT、简化乳腺MRI(BMRI-AP)与全诊断序列乳腺MRI(BMRI-FDP)在不同乳腺密度类型中诊断早期乳腺癌的效能。在致密型乳腺中,BMRI-FDP效能最佳,其次为BMRI-AP,再次为DBT,最后为FFDM;在非致密型乳腺中四种方法表现相当。BMRI-AP与BMRI-FDP诊断效果相近,但前者仍可能漏掉少数形态规则、有早期强化但无快速强化特征的病灶。
要点
- 致密型乳腺应优先选择乳腺MRI,BMRI-FDP与BMRI-AP均优于FFDM和DBT。
- 非致密型乳腺中四种检查方法诊断效能相当,可酌情选择检查方式。
- BMRI-AP可能漏诊少数形态规则且有早期强化但无快速强化特征的病灶。
核心结论
- 在致密型乳腺中,BMRI-FDP诊断早期乳腺癌效能最佳,其次为BMRI-AP,再次为DBT,最后为FFDM。
- 在非致密型乳腺中,FFDM、DBT、BMRI-AP与BMRI-FDP诊断效能相当。
- BMRI-AP与BMRI-FDP诊断效果相近,但BMRI-AP仍可能漏掉少数形态规则、有早期强化特征但无快速强化特征的病灶,本研究中此类病例比例为0.83%。
研究设计与样本
- 研究设计为基于病理结果对FFDM、DBT、BMRI-AP和BMRI-FDP进行诊断效能比较。
- 采用受试者工作特征曲线分析评估不同检查方法诊断乳腺癌的效能。
- 原文未报告样本量、中心数、设备型号与具体序列参数。
关键影像表现/征象
- BMRI-AP可能漏掉的病灶特征为:形态规则、具有早期强化特征但不表现快速强化。
诊断标准与关键数值
- 致密型乳腺中,FFDM、DBT、BMRI-AP和BMRI-FDP的准确度分别为82.7%、88.9%、94.1%和94.5%(P<0.05)。
- 致密型乳腺中,FFDM、DBT、BMRI-AP和BMRI-FDP的敏感度分别为83.0%、89.8%、94.2%和94.7%(P<0.05)。
- 致密型乳腺中,FFDM、DBT、BMRI-AP和BMRI-FDP的特异度分别为81.9%、86.8%、94.0%和94.0%(P<0.05)。
- 致密型乳腺中,FFDM、DBT、BMRI-AP和BMRI-FDP诊断早期乳腺癌的AUC分别为0.825、0.883、0.941和0.943。
- 致密型乳腺中,BMRI-AP与BMRI-FDP的AUC差异无统计学意义;两者AUC均大于FFDM和DBT(P<0.05)。
临床应用与阅片要点
- 致密型乳腺建议将乳腺MRI纳入早期乳腺癌筛查或诊断流程,优先考虑BMRI-FDP或BMRI-AP。
- 在资源受限或需缩短检查时间时,BMRI-AP可作为全序列MRI的替代方案,但需警惕漏诊少数不典型强化病灶。
- 非致密型乳腺中可结合临床条件在FFDM、DBT、BMRI-AP和BMRI-FDP之间选择,多种方法诊断效能接近。
局限性
- 原文未报告样本量、研究中心数量、入组标准及参考标准细节。
- 原文未说明BMRI-AP与BMRI-FDP具体序列构成及判读方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: The aim of the study is to compare the detection performance of full-field digital mammography (FFDM), digital breast tomosynthesis (DBT), breast magnetic resonance imaging protocol (BMRI-AP) and BMRI-full diagnostic protocol (FDP) for early breast cancer in different breast density types.
MATERIALS AND METHODS: Based on the pathological results, the receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic efficacy of different examination methods for breast cancer.
RESULTS: For dense breasts, the accuracy, sensitivity, and specificity of FFDM, DBT, BMRI-AP, and BMRI-FDP were, respectively, 82.7%, 88.9%, 94.1%, and 94.5% (P < 0.05); 83.0%, 89.8%, 94.2%, and 94.7% (P < 0.05); and 81.9%, 86.8%, 94.0%, and 94.0% (P < 0.05). The area under the curve (AUC) values for diagnosing early-stage breast cancer were 0.825, 0.883, 0.941, and 0.943, and there was no statistically significant difference between BMRI-AP and BMRI-FDP (P < 0.05). The AUC values for diagnosing early-stage breast cancer with BMRI-AP and BMRI-FDP were greater than those of FFDM and DBT (P < 0.05); the AUC for diagnosing early-stage breast cancer with DBT was greater than that of FFDM (P < 0.05). For nondense breasts, BMRI-FDP had the highest accuracy, at 95.0%, and sensitivity, at 94.1%. FFDM, DBT, and BMRI-AP showed equal performance (accuracy: 92.5%, sensitivity: 91.2%).
CONCLUSION: For dense breasts, the BMRI-FDP showed the best efficacy in diagnosing early breast cancer, followed by BMRI-AP, then DBT and finally FFDM. FFDM, DBT, BMRI-AP and BMRI-FDP performed equally well in non-dense breasts. Although the diagnostic effects of BMRI-AP and BMRI-FDP were comparable, there was still a possibility of missing some lesions that had regular shapes and early enhancement features but do not exhibit rapid enhancement. However, the proportion of such cases was very small (0.83% in this study).
引用
- Zhang, Zhou, Dao, et al. Comparative performance of mammography, abbreviated-protocol breast magnetic resonance imaging (MRI), and full diagnostic protocol breast magnetic resonance imaging (MRI) in diagnosing early breast cancer. Clin Radiol. 2026. PMID: 42585967. doi:10.1016/j.crad.2026.107421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。